EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ERM Inhibition Confers Ferroptosis Resistance through ROS‐Induced NRF2 Signaling

Menghao Qiao, Liqun Zhou, Minhua Zhou, Yu Fang, Haiying Mai, Lingbo Cao, Kun Xu, Yuan Sang, Minyi Chen, Jiewei Huang, Peiyi Huang, Zhipeng Yan und 8 weitere

Advanced Science · 2026-03 · 13 (16)

DOI: 10.1002/advs.202513310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.01.2026. Verfasst von Menghao Qiao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Department of Developmental & Regener…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, NF-E2-Related Factor 2, Ezrin, Cytoskeletal Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China, Research Fund for International Excellent Young Scientists (RFIS-II).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is an iron‐dependent form of programmed cell death governed by redox homeostasis. Although Ezrin, Radixin, and Moesin (ERM) proteins are established membrane‐actin cytoskeleton linkers, their role in ferroptosis remains unexplored. Here, ERM proteins are identified as modulators of erastin‐induced ferroptosis. In human fibrosarcoma HT‐1080 cells, pharmacological inhibition of ERM phosphorylation, knockdown of individual ERM members, or overexpression of a phospho‐deficient Ezrin mutant (T567A) consistently attenuated ferroptosis, whereas wild‐type ERM overexpression enhances ferroptosis susceptibility. Mechanistically, ERM inhibition leads to F‐actin depolymerization accompanied by a modest rise in reactive oxygen species (ROS). F‐actin stabilization prevents this ROS surge and restores ferroptotic sensitivity, whereas its depolymerization mimics the protective effect of ERM inhibition. ROS elevation triggers KEAP1 degradation, stabilizing NRF2 and promoting its nuclear translocation. Activated nuclear NRF2 induces antioxidant genes, particularly HMOX1 , a key effector of heme catabolism that enhances redox buffering and limits lipid peroxidation, ultimately conferring resistance to ferroptosis. The protective effects of ERM inhibition are further validated in ferroptosis‐relevant ex vivo and in vivo models. Notably, other pro‐oxidants similarly attenuate ferroptosis at appropriate concentrations. Together, these results establish ERM proteins as regulators of ferroptosis and reveal an underappreciated group of ferroptosis inhibitors that engage ROS‐NRF2‐mediated redox‐adaptation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesNF-E2-Related Factor 2EzrinCytoskeletal ProteinsMembrane ProteinsMicrofilament ProteinsSignal TransductionHumansCell Line, TumorFerroptosisAnimals

Stichwörter der Autor:innen

ActinERM proteinsFerroptosisHMOX1NRF2ROS

Substanzen

Reactive Oxygen SpeciesNF-E2-Related Factor 2EzrinradixinCytoskeletal ProteinsMembrane ProteinsmoesinMicrofilament ProteinsNFE2L2 protein, human

Autor:innen und Institutionen

  • Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Department of Developmental & Regenerative Medicine, College of Life Science and Technology, Jinan Universi…
  • Department of Cardiology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.
  • Zhejiang University-University of Edinburgh Institute, Zhejiang University, Hangzhou, China.
  • Department of Joint and Trauma Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Department of Pathology, Central People's Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, China.
  • Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University Zhanjiang Central Hospital, Zhanjiang, China.

ORCID-Profile: Junqi Huang

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • National Natural Science Foundation of China
  • Research Fund for International Excellent Young Scientists (RFIS-II)
  • Guangdong Innovative and Entrepreneurial Research Team Program
  • Guangzhou Basic and Applied Basic Research Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Qiao, M., Zhou, L., Zhou, M., Fang, Y., Mai, H., Cao, L., Xu, K., Sang, Y., Chen, M., Huang, J., Huang, P., Yan, Z., Wang, C., Dai, Z., Huang, D., He, R., Pang, L., Guo, Y., Chew, T. G., & Huang, J. (2026). ERM Inhibition Confers Ferroptosis Resistance through ROS‐Induced NRF2 Signaling. Advanced Science, 13(16). https://doi.org/10.1002/advs.202513310

Vancouver

Qiao M, Zhou L, Zhou M, Fang Y, Mai H, Cao L, et al. ERM Inhibition Confers Ferroptosis Resistance through ROS‐Induced NRF2 Signaling. Advanced Science. 2026;13(16). doi:10.1002/advs.202513310

BibTeX
@article{Qiao2026,
  author = {Qiao, Menghao and Zhou, Liqun and Zhou, Minhua and Fang, Yu and Mai, Haiying and Cao, Lingbo and Xu, Kun and Sang, Yuan and Chen, Minyi and Huang, Jiewei and Huang, Peiyi and Yan, Zhipeng and Wang, Chao and Dai, Zhangshuai and Huang, Dichun and He, Ronghan and Pang, Lijuan and Guo, Yunmiao and Chew, Ting Gang and Huang, Junqi},
  title = {ERM Inhibition Confers Ferroptosis Resistance through ROS‐Induced NRF2 Signaling},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {16},
  doi = {10.1002/advs.202513310}
}
Kostenlos starten →